Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fructose Injection in Acute Ischemic Stroke
NCT07626541Phase 2Active, not recruiting
- Start
- Jun 2026
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Fructose Diphosphate Sodium Injection in ischemic stroke (2 arms). Primary endpoint: National Institutes of Health Stroke Scale at 7 days. Started Jun 2026; status: active, not recruiting.
02
Drugs
Fructose Diphosphate Sodium Injection
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07626541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07626541.